Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06506630
NA
Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome
Sponsor: Tian Zezhong
View on ClinicalTrials.gov
Summary
This study aims to evaluate the ameliorating effect of coenzyme Q10 supplementation on cardiovascular risk factors in high risk population for metabolic syndrome, including blood lipid metabolism, insulin resistance, blood pressure regulation, platelet function, endothelial function, cardiorespiratory fitness and muscle function.
Key Details
Gender
All
Age Range
30 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2023-09-11
Completion Date
2024-12-30
Last Updated
2024-07-17
Healthy Volunteers
No
Interventions
DIETARY_SUPPLEMENT
coenzyme Q10
300 mg capsule twice a day
DIETARY_SUPPLEMENT
placebo
300 mg capsule twice a day
Locations (1)
School of Public Health (Shenzhen), Sun Yat-sen University
Shenzhen, China